PM BranIn

Nazione: Australia

Lingua: inglese

Fonte: Department of Health (Therapeutic Goods Administration)

Principio attivo:

Bacopa monnieri, Quantity: 150 mg (Equivalent: Bacopa monnieri, Qty 3 g)

Commercializzato da:

Pharmametics Products A Division of Max Biocare Pty Ltd

INN (Nome Internazionale):

Bacopa monnieri

Forma farmaceutica:

Capsule, hard

Composizione:

Excipient Ingredients: colloidal anhydrous silica; Gelatin; croscarmellose sodium; microcrystalline cellulose; purified water; magnesium stearate; calcium hydrogen phosphate dihydrate; sodium lauryl sulfate; sodium propionate

Via di somministrazione:

Oral

Indicazioni terapeutiche:

Antioxidant/Reduce free radicals formed in the body ; Enhance/improve/promote/increase cognitive performance ; Maintain/support cognitive function/mental function ; Maintain/support learning and information processing ; Enhance/improve/promote learning ability/function ; Enhance/improve/promote/increase memory/recall ; Maintain/support memory/mental recall ; Maintain/support general mental wellbeing ; Maintain/support brain function

Dettagli prodotto:

Visual Identification: ;

Stato dell'autorizzazione:

Licence status A

Data dell'autorizzazione:

2005-06-09